Approval · Notice of Compliance 4005 · 1997
OXY-IR: Notice of Compliance 4005
Issued August 1, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4005
- Date
- August 1, 1997
- Company
- Purdue Frederick
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Opioid analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OXY-IR | 02231934 | Marketed |
Medicinal ingredients
- OXYCODONE HYDROCHLORIDE 5 MG per TAB